Profile Image

Staff Profile

Edit

Career Summary

Biography

Professor Shu Chuen Li is Chair Professor and Discipline Convenor, Discipline of Pharmacy and Experimental Pharmacology.

Before taking up the present position, Professor Li has worked as an academic at the National University of Singapore and as Acting Director and Deputy Director, Pharmaceutical Evaluation Section (PES) of Pharmaceutical Benefits Branch, Commonwealth Department of Health & Ageing in Canberra.

During his period in Singapore, besides his academic appointment, Professor Li also served as the Visiting Specialist and Consultant to the Health Sciences Authority (which is the Singaporean equivalent of FDA in the USA and TGA in Australia). In this capacity, Professor Li has been instrumental in developing the Pharmacoeconomics and Drug Utilization Unit at the Centre for Drug Administration, Health Sciences Authority and in organizing several of the first ever pharmaceoconomics and outcomes conferences in the region. In his capacity as Acting Director and Deputy Director of PES in Australia, Professor Li was among the few pioneers that put the principles of pharmacoeconomic evaluation into practice for regulatory affairs, and has been involved in the implementation of the first version of the Australian Pharmacoeconomics Guidelines and the development of the second version of the same Guidelines.

Professor Li has been very active in his research area of pharmacoeconomics and outcomes research as well as pharmacy practice. He has published more than 250 peer review articles and conference abstracts on the subjects. In the past few years, Professor Li has been invited to present more than 100 lectures and panel speeches about pharmacy practice, drug policies and pharmacoeconomic applications in various countries and jurisdictions.

Professor Li was a Director on the ISPOPR Board of Directors from 2006 to 2008, and a founding member of the ISPOR Asia Consortium. Based in the United States, ISPOR is the peak academic society on pharmacoeconomics and outcomes research worldwide.

Besides the aforementioned commitments, Professor Li also holds many other consultative positions in Australia and in various Asian countries. The main ones include:

1. Visiting Professor, Department of Pharmacy, National University of Singapore

2. Visiting Professor, School of Pharmacy, Fudan University, China

3. Visiting Professor, Faculty of Pharmaceutical Science, Prince of Songkla University in Thailand.

4.Visiting Specialist/Consultant, Centre for Drug Administration, Health Sciences Authority, Singapore

5. Visiting Specialist/Consultant, Centre for Health Services Research, Yong Loo Lin School of Medicine, National University of Singapore.

Qualifications

  • PhD, Monash University, 08/12/1993
  • Bachelor of Pharmacy, South Australian Institute of Technology, 29/05/1978
  • Master of Business Administration, 22/10/1996
  • Health Economics (Distance Education), Monash University, 16/04/1997
  • Post Graduate Diploma in Management, Deakin University, 13/10/1995
  • Master of Applied Science, South Australian Institute of Technology, 02/05/1983

Research

Research keywords

  • Clinical Pharmacy
  • Cost-effectiveness studies
  • Drug Policy
  • Health economics
  • Health services research
  • Outcomes Research
  • Patient reported outcomes studies
  • Pharmacoeconomics
  • Pharmacoepidemiology

Research expertise

I have been involved with research in clinical pharmacy for more than 20 years. Recently, my research interest has been concentrated more on the areas of pharmacoeconomics and outcomes research, as well as drug policy. As a matter of fact, I would be considered as one of the pioneers in applying pharmacoeconomics in drug regulation, as I was involved with the first implementation of the first ever published pharmacoeconomics guidelines in drug reimbursement when I worked for the Commonwealth Government in Australia.

Languages

  • Cantonese
  • English
  • Hakka
  • Mandarin

Fields of Research

CodeDescriptionPercentage
110300Clinical Sciences45
111700Public Health And Health Services40
111299Oncology And Carcinogenesis Not Elsewhere Classified15

Appointments

Board of Directors
International Society of Pharmacoeconomics & Outcomes Research (ISPOR) (United States)
01/05/2006
Visiting Professor
National University of Singapore (Singapore)
01/04/2007
Visiting Professor
Fudan University (China)
01/05/2007

Invitations

1st National Health Outcomes and Pharmacoeconomics Symposium
National University of Singapore, Pfizer Asia and Tan Tock Seng Hospital, Singapore (Chair of theOrganizing Committee)
2003
. Pre-Conference Workshop, Regional Conference on Cost-effective Healthcare,
SGH Postgraduate Medical Institute Healthcare Management Development Programme, Singapore (Conference Presentation - non published.)
2004
15th Annual Scientific Meeting
Singapore General Hospital, Singapore (Conference Presentation - non published.)
2006
1st National Health Outcomes Conference
Association Of Public Health Medical Specialist and Pfizer Malaysia Sdn. Bhd, Malaysia (Conference Presentation - non published.)
2004
1st VALID Study Steering Committee Meeting,
Sanofi-Aventis, United Kingdom (Conference Presentation - non published.)
2003
21st Federation of Asian Pharmaceutical Associations (FAPA) Congress
FAPA, Japan (Conference Presentation - non published.)
2005
Advanced GCP course on Pharmacovigilance
Yong Loo Lin School of Medicine, National University of Singapore, Singapore (Conference Presentation - non published.)
2006
Asian Pacific Forum on New Therapies in Rheumatic Diseases.
National Arthritis Foundation, Singapore (Conference Presentation - non published.)
2002
Co-sponsor Special Session at ISPOR 2nd Asia Pacific Conference
ISPOR & Various regulatory authroities in Asia, China (Conference Presentation - non published.)
2006
Conference on Quality of Life in Asia
Hong Kong Society for Quality of Life, Academy of Medicine, Hong Kong (Conference Presentation - non published.)
2007
Dinner Symposium: New advances on lipid lowering therapy.
Pharmaceutical Society of Singapore, Singapore (Conference Presentation - non published.)
2003
Health Economic Symposium
Vietnamese Ministry of Health & Sanofi-Aventis, Viet Nam (Conference Presentation - non published.)
2005
Health Policy Dinner Symposium
Fudan University and Chinese University of Hong Kong , China (Conference Presentation - non published.)
2007
IMS Special Symposium at ISPOR 2nd Asia Pacific Conference
IMS & ISPOR, China (Conference Presentation - non published.)
2006
International Workshop on Pharmacoeconomics:
Indonesian Ministry of Health, Indonesia (Conference Presentation - non published.)
2002
Intervarsity Symposium Singapore, 17th Singapore Pharmacy Congress
Pharmaceutical Society of Singapore & National University of Singapore, Singapore (Conference Presentation - non published.)
2005
Panel Discussion at ISPOR First Asian Pacific Conference
ISPOR, Japan (Conference Presentation - non published.)
2003
Patient Reported Outcomes for Clinical Research Workshop.17th Singapore Pharmacy Congress
Pharmaceutical Society of Singapore, Singapore (Conference Presentation - non published.)
2005
Pre-Conference Workshop at ISPOR 2nd Asia Pacific Conference
ISPOR, China (Conference Presentation - non published.)
2006
Proceedings of International Congress of Indian Pharmacy Graduate
Pharmaceutical Society of India, India (Conference Presentation - non published.)
2003
Regional Conference on Cost-effective Healthcare
SGH Postgraduate Medical Institute Healthcare Management Development Programme, Singapore (Conference Presentation - non published.)
2004
Regional Conference on Cost-effective Healthcare,
SGH Postgraduate Medical Institute Healthcare Management Development Programme, Singapore (Conference Presentation - non published.)
2004
Second Regional Conference on Cost-effective Healthcare
SingHealth Postgraduate Medical Institute, Singapore (Conference Presentation - non published.)
2006
TASPOR Annual Health Economics Meeting and Symposium
TASPOR, Taiwan (Conference Presentation - non published.)
2005
Third Annual Scientific Meeting
Johor State Department of Health, Malaysia (Conference Presentation - non published.)
2001
Third International Asian Conference on Cancer Screening
Health Promotion Board, Singapore (Conference Presentation - non published.)
2006
Workshop on Healthcare Financing
Pharmaceutical Association of Malaysia, Malaysia (Conference Presentation - non published.)
2002
Symposium on New Standard for Hepatitis B Management
Chapter of Gastroenterologists, College of Physicians, Singapore, Singapore (Dinner symposium)
2006
Pfizer Global Pharmaceuticals Outcomes Research Training Programme Part 1
Pfizer Asia, Singapore (Invited Training Workshop for Asia-Pacific Region)
2005
Pfizer Outcomes Research Coordinators of Asia Training Program Part 2
Pfizer Asia, Singapore (Invited Training Workshop for Asia-Pacific Region)
2005
Training Workshop for National Healthcare Group College
National Healthcare Group, Singapore (Invited Workshop)
2006
COFM Public Health Update Forum
Chapter of Public Health & Occupational Physicians, Academy of Medicine, Singapore and Department of Community, Occupational and Family Medicine, Faculty of Medicine, National University of Singapore., Singapore (Invited talk)
2005
Dinner Symposium of Osteoporosis Society of Singapore
Osteoporosis Society of Singapore Special Interest Group Meeting,, Singapore (Invited talk)
2005
Invited Lecture
Kyoto University, Japan (Invited talk)
2002
Invited Lecture
Centre of Pharmaceutical Administration, Health Sciences Authority, Singapore (Invited talk)
2001
Invited Lecture
Institute of Health Economics and Policy, Japan (Invited talk)
2002
Invited Lecture
National Healthcare Group P & T Co-ordinating Committee, Singapore (Invited talk)
2002
Invited Lecture
University of Tokyo, Japan (Invited talk)
2002
Invited Lecture
at Faculty of Pharmaceutical Sciences, Prince of Songkla University, Thailand (Invited talk)
2004
Invited Talk
School of Pharmacy, Fudan University, China (Invited talk)
2006
Invited Talk
Centre for Pharmaceutical Administration, Health Sciences Authority, Singapore (Invited talk)
2005
Presentation Talk at Science Focus for Teachers Program
Ministry of Education & Faculty of Science, National University of Singapore, Singapore (Invited talk)
2005
Medical Decision Workshop
Tan Tock Seng Hospital, Singapore, Institute of Medical Education and Training (IMET), NHG College, Singapore (Invited workshop)
2004
Post Conference Workshop, 1st National Health Outcomes Conference
Association Of Public Health Medical Specialist and Pfizer Malaysia Sdn. Bhd, Malaysia (Invited workshop)
2004
Pre-conference workshop of ISPOR First Asian Pacific Conference
ISPOR, Australia (Invited workshop)
2003
Pharmacoeconomics for Pharmacists Workshop
Pharmaceutical Society of Singapore, Singapore (Invited workshop and Talk)
2002
Third Asia Pacific Evidence-Based Medicine Conference and Workshop,
National University of Singapore & McMaster University of Canada, Singapore (Invited workshop and Talk)
2005
15th Singapore Pharmacy Congress
Pharmaceutical Society of Singapore, Singapore (Plenary Speech)
2002
An Evidence Based and Pharmacoeconomic Approach to Drug Prescribign Seminar
National University Hospital Pharmacy and Therapeutics Committee, Singapore (Plenary Speech)
2001
First International Pharmaceutical Students Federation Asian Pacific Symposium
IPSF of FIP, Singapore (Plenary Speech)
2001
2nd VALID Steering Committee Meeting
Sanofi-Aventis, Thailand (Research syposium)
2004
Roundtable Discussion for Chinese Delegation. ISPOR First Asian Pacific Conference,
GSK, Japan (Special Invited Round table discussion)
2003
Continuous Education Lecture
Pharmaceutical Society of Singapore Industry Chapter, Singapore ( )
2006
Faculty of Science Lunchtime Seminar
Faculty of Science, National University of Singapore, Singapore ( )
2006

Administrative

Administrative expertise

I have been the acting director and deputy director at one of the Commonwealth Government department in Canberra for around 5 years. Before that I held senior pharmacist position as well as chief pharmacist and chief hospital administrator in Republic of Nauru for a period of 2 years.

During the course of my career, I have been involved in handling many adminsitrative decisions and I have completed a degree of Master of Business Administration to provide the theoretcial consolidation of my administrative experience.

Teaching

Teaching keywords

  • Biostatistics
  • Clinical Pharmacy Practice
  • Critical Literature Evaluation
  • Pharmacoeconomics
  • Pharmacoepidemiology
  • Pharmacotherapeutics

Teaching expertise

I have been teaching pharmacoeconomics and outcomes research as well as pharmacotherapy for nearly 10 years. I have also been invited to provide lectures and workshops around the South-east Asian region during my period working at the National University of Singapore. I have also conducted courses for critical literature evaluation and biostatistics at the graduate level for nearly 10 years.

Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Journal article (145 outputs)

YearCitationAltmetricsLink
2014Gao L, Xia L, Pan SQ, Xiong T, Li SC, 'Reliability and validity of QOLIE-10 in measuring health-related quality of life (HRQoL) in Chinese epilepsy patients.', Epilepsy Res, 108 565-575 (2014)
2013Zhao F, Gao L, Li S, 'Burden of Disease Studies in the Asia-Pacific Region: Are There Enough being Performed to Provide Information for Evidence-Based Health Policy?', Value in Health Regional Issues, 2 152-159 (2013) [C1]
2013Zhang F, Xie J, Zhang Y, Kong L, Li S, '"What Is Important During the Selection of Traditional Chinese Medicine (TCM) in a Health Care Reimbursement or Insurance System?" Critical Issues of Assessment from the Perspective of TCM Practitioners', Value in Health Regional Issues, 2 141-146 (2013) [C1]
2013Zhao YJ, Tan LCS, Au WL, Heng DMK, Soh IAL, Li SC, et al., 'Estimating the lifetime economic burden of Parkinson's disease in Singapore', EUROPEAN JOURNAL OF NEUROLOGY, 20 368-374 (2013)
2013Gao L, Xia L, Zhao F-L, Li S-C, 'Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: A meta-analysis of randomized placebo-controlled trials', EPILEPSY RESEARCH, 103 31-44 (2013)
2013Gao L, Walterfang M, Velakoulis D, Li SC, 'PND9 - Validation of a chinese version of neuropsychiatry unit cognitive assessment tool (NUCOG)', Value in Health, 16 A101 (2013)
2013Gao L, Xia L, Pan S-Q, Xiong T, Li S-C, 'Validation of a Chinese version of the Quality of Well-Being Scale-Self-Administered (QWB-SA) in patients with epilepsy', EPILEPSIA, 54 1647-1657 (2013)
2013Zhou HJ, Li SC, Naidoo N, Zhu F, Yeoh KG, 'Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010', BMC HEALTH SERVICES RESEARCH, 13 (2013)
2012Zhang F, Kong L-L, Zhang Y-Y, Li SC, 'Evaluation of impact on health-related quality of life and cost effectiveness of traditional chinese medicine: A systematic review of randomized clinical trials', Journal of Alternative and Complementary Medicine, 18 1108-1120 (2012) [C1]
2012Tu HAT, Woerdenbag HJ, Riewpaiboon A, Kane S, Le DM, Postma MJ, Li SC, 'Cost of illness of chronic hepatitis B infection in Vietnam', Value in Health Regional Issues, 1 23-28 (2012) [C1]
2012Thoopputra T, Newby DA, Schneider JJ, Li SC, 'Survey of diabetes risk assessment tools: Concepts, structure and performance', Diabetes/Metabolism Research and Reviews, 28 485-498 (2012) [C1]

Co-authors: David Newby

2012Tu H-AT, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ, 'Health economics of rotavirus immunization in Vietnam: Potentials for favorable cost-effectiveness in developing countries', Vaccine, 30 1521-1528 (2012) [C1]
2012Zhou HJ, So JBY, Yong WP, Luo N, Zhu F, Naidoo N, et al., 'Validation of the functional assessment of cancer therapy-gastric module for the Chinese population', Health and Quality of Life Outcomes, 10 1-8 (2012) [C1]
2012Tu HAT, De Vries R, Woerdenbag HJ, Li SC, Le HH, Van Hulst M, Postma MJ, 'Cost-effectiveness analysis of hepatitis B immunization in Vietnam: Application of cost-effectiveness affordability curves in health care decision making', Value in Health Regional Issues, 1 7-14 (2012) [C1]
2012Zhang X-H, Tan K, Tan H-H, Thumboo J, Li SC, 'Are English and Chinese versions of the audit of diabetes-dependent quality of life equivalent? An exploratory study based on the universalist approach', Value in Health Regional Issues, 1 75-81 (2012) [C1]
2012Zhang X-H, Li SC, Xie F, Lo N-N, Yang K-Y, Yeo S-J, et al., 'An exploratory study of response shift in health-related quality of life and utility assessment among patients with osteoarthritis undergoing total knee replacement surgery in a tertiary hospital in Singapore', Value in Health, 15 S72-S78 (2012) [C1]
2012Gao L, Zhao F, Li SC, 'Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China', International Journal of Technology Assessment in Health Care, 28 436-444 (2012) [C1]
2012Gao L, Zhao F, Li SC, 'Statin is a reasonable treatment option for patients with polycystic ovary syndrome: A meta-analysis of randomized controlled trials', Experimental and Clinical Endocrinology and Diabetes, 120 367-375 (2012) [C1]
2011Li SC, Aggarwal SK, 'Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study', Journal of Medical Economics, 14 350-356 (2011) [C1]
2011Tu H-AT, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ, 'Economic evaluations of rotavirus immunization for developing countries: A review of the literature', Expert Review of Vaccines, 10 1037-1051 (2011) [C1]
2011Zhao F, Yue M, Yang H, Wang TA, Wu J-H, Li SC, 'Willingness to pay per quality-adjusted life year: Is one threshold enough for decision-making? Results from a study in patients with chronic prostatitis', Medical Care, 49 267-272 (2011) [C1]
2011Zhao YJ, Tan LCS, Li SC, Au WL, Seah SH, Lau PN, et al., 'Economic burden of Parkinson's disease in Singapore', European Journal of Neurology, 18 519-526 (2011) [C1]
2011Zhao YJ, Wee HL, Au WL, Seah SH, Luo N, Li SC, Tan LCS, 'Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times', Parkinsonism and Related Disorders, 17 194-197 (2011) [C1]
2011Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC, 'Extension from inpatients to outpatients: Validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis', International Journal of Rheumatic Diseases, 14 206-210 (2011) [C1]
2011Zhao YJ, Wee HL, Au WL, Seah SH, Luo N, Li SC, Tan LCS, 'Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr stage transition times (vol 17, pg 194, 2011)', PARKINSONISM & RELATED DISORDERS, 17 299-300 (2011) [C3]
2010Zhao YJ, Wee HL, Chan Y-H, Seah SH, Au WL, Lau PN, et al., 'Progression of Parkinson's Disease as evaluated by Hoehn and Yahr stage Transition times', Movement Disorders, 25 710-716 (2010) [C1]
2010Soon SS, Goh SY, Bee YM, Poon JL, Li SC, Thumboo J, Wee HL, 'Audit of diabetes-dependent quality of life (ADDQoL) Chinese version for Singapore questionnaire: Reliability and validity among Singaporeans with type 2 diabetes mellitus', Applied Health Economics and Health Policy, 8 239-249 (2010) [C1]
2010Shi LZ, Hodges M, Drummond M, Ahn J, Li SC, Hu S, et al., 'Good research practices for measuring drug costs in cost-effectiveness analyses: An international perspective: The ISPOR Drug Cost Task Force Report-Part VI', Value in Health, 13 28-33 (2010) [C1]
2010Zhao F, Yue M, Yang H, Wang T, Wu J-H, Li SC, 'Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome', Quality of Life Research, 19 1273-1283 (2010) [C1]
2010Ong SC, Lim SG, Li SC, 'Reliability and validity of a Chinese version's health-related quality of life questionnaire for Hepatitis B patients', Value in Health, 13 324-327 (2010) [C1]
2010Koh Y, Yap CW, Li SC, 'Development of a combined system for identification and classification of adverse drug reactions: Alerts Based on ADR Causality and Severity (ABACUS)', Journal of the American Medical Informatics Association, 17 720-722 (2010) [C2]
2009Zhang X-H, Thumboo J, Fong K-Y, Li SC, 'Development and validation of a Functional Health Literacy Test', The Patient: Patient-Centred Outcomes Research, 2 169-178 (2009) [C1]
2009Pongmesa T, Li SC, Wee H-L, 'A survey of knowledge on diabetes in the Central Region of Thailand', Value in Health, 12 S110-S113 (2009) [C1]
2009Zhang X-H, Jin J, Ngorsuraches S, Li SC, 'Development and validation of a scale to measure patients' trust in pharmacists in Singapore', Patient Preference and Adherence, 3 1-7 (2009) [C1]
2009Ong SC, Lim SG, Li SC, 'How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore', Journal of Viral Hepatitis, 16 53-63 (2009) [C1]
2009Ong SC, Lim SG, Li SC, 'Cultural adaptation and validation of a questionnaire for use in hepatitis B patients', Journal of Viral Hepatitis, 16 272-278 (2009) [C1]
2009Zhang XD, Li SC, Fong K-Y, Thumboo J, 'The Impact of Health Literacy on Health-Related Quality of Life (HRQoL) and utility assessment among patients with rheumatic diseases', Value in Health, 12 S106-S109 (2009) [C1]
2009Luo N, Tan LCS, Zhao Y, Lau P-N, Au W-L, Li SC, 'Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson's Disease Questionnaire (PDQ-8)', Movement Disorders, 24 183-187 (2009) [C1]
2009Yong C, Fisher DA, Sklar GE, Li SC, 'A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): An Asian perspective', International Journal of Antimicrobial Agents, 33 46-51 (2009) [C1]
2009Zhang X-H, Wee H-L, Tan K, Thumboo J, Li SC, 'Is diabetes knowledge associated with health-related quality of life among English-speaking subjects with diabetes in Singapore', Journal of Chinese Clinical Medicine, 4 144-150 (2009) [C2]
2008Jin J, Sklar GE, Oh VMS, Li SC, 'Factors affecting therapeutic compliance: A review of from the patient's perspective', Therapeutics and Clinical Risk Management, 4 269-286 (2008) [C1]
2008Wee H-L, Li SC, Xie F, Zhang X-H, Luo N, Feeny D, et al., 'Validity, feasibility and acceptability of time trade-off and standard gamble assessments in health valuation studies: A study in a multiethnic Asian population in Singapore', Value in Health, 11 S3-S10 (2008) [C1]
2008Xie F, Thumboo J, Fong K-Y, Lo N-N, Yeo S-J, Yang K-Y, Li SC, 'A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore', Value in Health, 11 S84-S90 (2008) [C1]
2008Wee H-L, Cheung Y-B, Loke W-C, Tan C-B, Chow M-H, Li SC, et al., 'The association of body mass index with health-related quality of life: An exploratory study in a multiethnic Asian population', Value in Health, 11 S105-S114 (2008) [C1]
2008Zhao YJ, Tan LCS, Lau PN, Au WL, Li SC, Luo N, 'Factors affecting health-related quality of life amongst Asian patients with Parkinson's disease', European Journal of Neurology, 15 737-742 (2008) [C1]
2008Tarn TYH, Hu SL, Kamae I, Yang BM, Li SC, Tangcharoensathien V, et al., 'Health-care systems and pharmacoeconomic research in Asia-Pacific region', Value in Health, 11 S137-S155 (2008) [C1]
2008Ngorsuraches S, Lerkiatbundit S, Li SC, Sirithorn R, Korwiwattanakarn M, 'Development and Validation of Patient's Trust Scale in Community Pharmacist (Trust-Ph)', Research in Social and Administrative Pharmacy, 4 272-283 (2008) [C1]
2008Xie F, Lo NN, Lee HP, Cieza A, Li SC, 'Validation of the international classification of functioning, disability, and health (ICF) brief core set for osteoarthritis', Scandinavian Journal of Rheumatology, 37 450-461 (2008) [C1]
2008Wee H-L, Li SC, Zhang X-H, Xie F, Feeny D, Luo N, et al., 'Are symbols useful and culturally acceptable in health-state valuation studies? An exploratory study in a multi-ethnic Asian population', Patient Preference and Adherence, 2 271-276 (2008) [C1]
2008Luo N, Seng B-K, Xie F, Li SC, Thumboo J, 'Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore', Quality of Life Research, 17 115-122 (2008) [C1]
2008Koh Y, Yap CW, Li SC, 'A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system', International Journal of Medical Informatics, 77 421-430 (2008) [C1]
2008Lee KKC, Li SC, Kwong KS, Chan TYK, Lee VWY, Lau JTF, 'A study of the health and economic effects of influenza-like illness on the working population under different working environments of a large corporation in Hong Kong', Journal of Medical Economics, 11 639-650 (2008) [C1]
2008Zhang X-H, Xie F, Wee H-L, Thumboo J, Li SC, 'Applying the expectancy-value model to understand health values', Value in Health, 11 S61-S68 (2008) [C1]
2008Ong SC, Mak B, Aung MO, Li SC, Lim S-G, 'Health-related quality of life in chronic hepatitis B patients', Hepatology, 47 1108-1117 (2008) [C1]
2008Xie F, Li SC, Goeree R, Tarride J-E, O'Reilly D, Lo N-N, et al., 'Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement', Quality of Life Research, 17 595-601 (2008) [C1]
2008Li SC, 'Can pharmacoeconomic guidelines be implemented successfully in Asia?', Journal of Medical Economics, 11 341-343 (2008) [C3]
2008Li SC, Piggott C, 'A focus group study of barriers for female community pharmacists providing counselling for male sexual dysfunction', NSW Pharmacist, 15-16 (2008) [C3]
2007Xie F, Thumboo J, Li SC, 'True Difference or Something Else? Problems in Cost of Osteoarthritis Studies', Seminars in Arthritis and Rheumatism, 37 127-132 (2007) [C1]
2007Luo N, Wang Q, Feeny D, Chen G, Li SC, Thumboo J, 'Measuring health preferences for health utilities index mark 3 health states: A study of feasibility and preference differences among ethnic groups in Singapore', Medical Decision Making, 27 61-70 (2007) [C1]
2007Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, et al., 'Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement', Arthritis and Rheumatism, 57 1043-1049 (2007) [C1]
2007Xie F, Thumboo J, Lo NN, Yeo SJ, Yang KY, Yeo W, et al., 'Cross-Cultural Adaptation and Validation of Singapore English and Chinese Versions of the Lequesne Algofunctional Index of Knee in Asians with Knee Osteoarthritis in Singapore.', Osteoarthritis and Cartilage, 15 19-26 (2007) [C1]
2007Xie F, Lo NN, Lee HP, Cieza A, Li SC, 'Validation of the comprehensive ICF core set for Osteoarthritis (OA) in patients with knee OA: A Singaporean perspective', Journal of Rheumatology, 34 2301-2307 (2007) [C1]
2007Wee HL, Ravens-Sieberer U, Erhart M, Li SC, 'Factor structure of the Singapore English version of the KINDL (R) children quality of life questionnaire', Health and Quality of Life Outcomes, 5 (2007) [C1]
2007Wee H-L, Li SC, 'Sociodemographic factors influencing the effectiveness of public health education: A comparison of two studies in Singapore', Annals Academy of Medicine Singapore, 36 958-961 (2007) [C1]
2007Xie F, Thumboo J, Li SC, 'Direct and Indirect Costs of Osteoarthritis: A Perspective from Multiethnic Asian Patients with Osteoarthritis in Singapore', Journal of Rheumatology, 34 165-171 (2007) [C1]
2007Wee HL, Loke WC, Li SC, Fong KY, Cheung YB, Machin D, et al., 'Cross-cultural adaptation and validation of Singaporean Malay and Tamil versions of the EQ-5D', Annals of the Academy of Medicine Singapore, 36 403-408 (2007) [C1]
2007Wee HL, Machin D, Loke WC, Cheung YB, Li SC, Luo N, et al., 'Assessing Systematic Differences in Utility Scores: A comparison of four widely used preference-based instruments', Value in Health, 10 256-265 (2007) [C1]
2007Li SC, 'Health care system and public sector drug formulary in Singapore', ISPOR Connections, 13 4-7 (2007) [C2]
2007Li SC, 'How to improve pharmacoeconomic data generalisability between different countries', Expert Opinion on Pharmacotherapy, 8 1409-1413 (2007) [C3]
2007Xie F, Li S-C, Lo N-N, Yeo S-J, Yang K-Y, Yeo W, et al., 'Cross-cultural adaptation and validation of Singapore English and Chinese Versions of the Oxford Knee Score (OKS) in knee osteoarthritis patients undergoing total knee replacement', OSTEOARTHRITIS AND CARTILAGE, 15 1019-1024 (2007)
2007Xie F, Thumboo J, Fong K-Y, Lo N-N, Yeo S-J, Yang K-Y, Li S-C, 'Direct and indirect costs of OA in Singapore: A comparative study among multiethnic Asian patients', JOURNAL OF RHEUMATOLOGY, 34 165-171 (2007)
2007Zhang XH, Li SC, Xie F, Lo NN, Yang KY, Yeo SJ, Thomboo J, 'Investigation of response shift in health-related quality of life among patients undergoing total knee replacement', VALUE IN HEALTH, 10 A253-A253 (2007)
2006Wee HL, Li SC, Xie F, Zhang XH, Luo N, Cheung YB, et al., 'Are Asians comfortable with discussing death in health valuation studies? A qualitative study in multi-ethnic Singapore.', Health and Quality of Life Outcomes, 4 93-93 (2006) [C1]
2006Wee HL, Tan CE, Goh SY, Li SC, 'Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQOL) Questionnaire Patients with Diabetes in a multi-ethnic Asian country', PharmacoEconomics, 24 673-682 (2006) [C1]
2006Luo N, Seng BK, Thumboo J, Feeney D, Li SC, 'A Study of the Construct Validity of the Health Utilities Index Mark 3 (HUI3) in Patients with Schizophrenia', Quality of Life Research, 15 889-898 (2006) [C1]
2006Xie F, Li SC, Roos E, Lo NN, Yeo SJ, Yang KY, et al., 'Cross-Cultural Adaptation and Validation of Singapore English and Chinese Versions of the Knee Injury and Osteoarthritis Outcome Score (KOOS) in Asians with Knee Osteoarthritis in Singapore', Osteoarthritis and Cartilage, 14 1098-1103 (2006) [C1]
2006Xie F, Thumboo J, Fong KY, Lo NN, Yeo SJ, Yang KY, Li SC, 'Are They Relevant? A Critical Evaluation of the International Classification of Functioning, Disability and Health Core Sets for Osteoarthritis from the Perspective of Patients with Knee Osteoarthritis in Singapore', Annals of the Rheumatic Diseases, 65 1067-1076 (2006) [C1]
2006Ngorsuraches S, Li SC, 'Thai Pharmacists'' Understanding, Attitudes, and Perceived Barriers Related to the Provision of Pharmaceutical Care', American Journal of Health-System Pharmacy, 63 2144-2150 (2006) [C1]
2006Wee HL, Li SC, Cheung YB, Fong YH, Thumboo J, 'The Influence of ethnicity on Health-related Quality of Life in Diabetes Mellitus: A Population-based Multi-Ethnic Study.', Journal of Diabetes and Its Complications, 20 170-178 (2006) [C1]
2006Xie F, Li SC, Fong KY, Yeo SJ, Yang KY, Thumboo J, 'What Health Domains & Items Are Important to Patients with Knee Osteoarthritis? A Focus Group Study in a Multi-Ethnic Asian Population in Singapore', Osteoarthritis and Cartilage, 14 224-230 (2006) [C1]
2006Wee HL, Chua HX, Li SC, 'Meaning of Health-related Quality-of-Life among children and adolescents in an Asian country: A focus group approach', Quality of Life Research, 15 821-831 (2006) [C1]
2006Chong LY, Chay OM, Li SC, 'Is the Childhood Asthma Questionnaire (CAQ) a good measure of Health-related Quality of Life (HRQoL) of Asthmatic Children in Asia? Validation of Childhood Asthma Questionnaire (CAQ B) Among Asthma Pediatric Patients in Singapore', PharmacoEconomics, 24 609-621 (2006) [C1]
2006Zhang XH, Ngorsuraches S, Li SC, 'Development and Validation of a scale to measure patients trust in pharmacists', Value in Health, 9 (2006) [C1]
2006Zhang XH, Xie F, Wee HL, Thumboo J, Li SC, 'Applying the Expectancy-Value Model to understand Health Preference An Exploratory Study.', Value in Health, 9 (3) (2006) [C3]
2006Li SC, Ong SC, Lim SG, 'Health related quality of life in chronic hepatitis B patients', VALUE IN HEALTH, 9 A308-A308 (2006)
2005Xie F, Li SC, Thumboo J, 'Do the Important Health-Related Quality of Life Domains & Items in Knee & Hip Osteoarthritis Vary in Importance Across Social-Cultural Contexts? A Qualitative Systematic Literature Review', Seminars in Arthritis and Rheumatism, 34 793-804 (2005) [C1]
2005Koh Y, Fatimah MK, Li SC, 'Drug related problems in hospitalized patients on polypharmacy: The influence of age and gender', Therapeutics and Clinical Risk Management, 1 39-48 (2005) [C1]
2005Zhang XH, Wee HL, Tan K, Tan HH, Thumboo J, Li SC, 'Is Diabetes Knowledge Associated with Health-related Quality of Life among English-speaking Subjects with Diabetes in Singapore?', Value in Health, 8 365-366 (2005) [C1]
2005Xie F, Tan CH, Li SC, 'Are They Used Safely? A Study on Prescribing Pattern of Selective Serotonin Reuptake Inhibitors in Singapore', Human Psychopharmacology, 20 459-465 (2005) [C1]
2005Xie F, Thumboo J, Li SC, 'Are they Relevant? A Critical Evaluation of the International Classification of Functioning, Disability and Health Core Sets for Osteoarthritis from the Perspective of Patients with Knee Osteoarthritis in Singapore', Annals of the Rheumatic Diseases, 8 1067-1073 (2005) [C1]
2005Ong SC, Lim SG, Li SC, 'Validation of a Health-related Quality of Life Instrument for Hepatitis B patients in Singapore', Value in Health, 8 312-312 (2005) [C1]
2005Hing WC, Yeoh TT, Yeoh SF, Lin R, Li SC, 'An Evaluation of Antimicrobial Prophylaxis in Pediatric Surgery and its Financial Implications in Singapore', Journal of Clinical Pharmacy and Therapeutics, 30 371-381 (2005) [C1]
2005Chui WK, Li SC, 'Advice giving on self-medication by community pharmacists in Singapore', Journal of Clinical Pharmacy and Therapeutics, 30 225-231 (2005) [C1]
2005Wee HL, Cheung YB, Fong KY, Li SC, Thumboo J, 'The Impact of Diabetes and other Chronic Medical Conditions on Health-related Quality of Life: Is the Whole Greater than the Sum of its Parts?', Health and Quality of Life Outcomes, 3 1-2 (2005) [C1]
2005Lau TC, Lau TC, Lim BP, Lim BP, Li SC, 'Cost-Effectiveness Analysis of Bisphosphonates and Raloxifene for Treatment of Osteoporosis and Prevention of Fractures.', Value in Health, 8 (3) (2005) [C3]
2005Luo N, Tan LC, Li SC, Soh LK, Thumboo J, 'Validity and Reliability of the Chinese (Singapore) Version of the Parkinson''s Disease Questionnaire (PDQ-39).', Quality of Life Research, 14 273-279 (2005) [C3]
2005Luo N, Fones CS, Lim SE, Xie F, Thumboo J, Li SC, 'The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation of English Version in Singapore', Quality of Life Research, 14 1181-1186 (2005) [C3]
2005Wee HL, Lee WW, Ravens-Sieberer U, Erhart M, Li SC, 'Validation of the English Version of the KINDL Generic Children''s Health-related Quality of Life Instrument for an Asian Population - Results from a Pilot Test', Quality of Life Research, 14 1193-1200 (2005) [C3]
2005Zhang XH, Wee HL, Tan K, Tan K, Tan HH, Tan HH, et al., 'An Exploratory Study of the Equivalence between the English and Chinese Versions of the Audit of Diabetes-Dependent Quality of Life (ADDQOL) based on the Universalist Approach.', Quality of Life Research, 14 (2005) [C3]
2005Koh Y, Li SC, 'A New Algorithm to Identify the Causality of Adverse Drug Reactions: Development of Algorithm', Drug Safety 2005, 28 1159-1161 (2005) [C3]
2005Xie F, Thumboo J, Fong KY, Lo NN, Yeo SJ, Yang KY, Li SC, 'Are they relevant? A critical evaluation of the international classification of functioning, disability and health core sets for osteoarthritis from the perspective of patients with knee osteoarthritis in Singapore', VALUE IN HEALTH, 8 A27-A27 (2005)
2004Koh Y, Fatimah HK, Fatimah MK, Li SC, 'Prevalence of drug-related problems amongst hospitalised patients on polypharmacy in Singapore.', Value in Health, 7 (3) (2004) [C1]
2004Luo N, Koh Y, Tan CH, Kua EH, Li SC, 'Drug utilization review of risperidone for outpatients from a tertiary referral hospital in Singapore', Human Psychopharmacology, 19 259-264 (2004) [C1]
2004Gao F, Luo N, Thumboo J, Fones CS, Li SC, Cheung YB, 'Does the 12-item General Health Questionnaire contain multiple factors and do we need them?', Health and Quality of Life Outcomes, 2 63-63 (2004) [C1]
2004Li SC, Ong SC, Lim SG, Yeoh KG, Kwong SKS, Lee V, et al., 'A Cost Comparison of Management of Chronic Hepatitis B and its Associated Complications in Hong Kong and Singapore', Journal of Clinical Gastroenterology, 38 S136-S143 (2004) [C1]
2004Zhou S, Chan E, Lim LY, Boelsterli UA, Li SC, Wang J, et al., 'Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4', Current Drug Metabolism, 5 415-442 (2004) [C1]
2004Doherty J, Kamae I, Lee K, Li H, Li SC, Liu G, et al., 'What''s Next for Pharmacoeconomics and Outcomes Research in Asia?', Value in Health, 7 118-132 (2004) [C1]
2004Tsai WL, Chang HM, Hwu Y, Hsu PC, Tsai HI, Chow GM, et al., 'Imaging cells with refractive index radiology', Biophysical Journal, 87 4180-4187 (2004) [C1]
2004Hing WC, Bek SJ, Lin R, Li SC, 'Retrospective Drug Utilisation of Vancomycin in a paediatric hospital', Journal of Clinical Pharmacy and Therapeutics, 29 359-365 (2004) [C1]
2004Luo N, Fones CS, Thumboo J, Li SC, 'Factors influencing health-related quality of life in Asians with anxiety disorders in Singapore', Quality of Life Research, 13 557-565 (2004) [C3]
2004Wee HL, Goh SY, Li SC, Lim SG, Ong SC, Tan CE, Thumboo J, 'Is the influence of sociodemographic factors on EQ-5D scores affected by the underlying disease: A study in patients with chronic hepatitis B or diabetes mellitus.', Quality of Life Research, 13 (2004) [C3]
2003Luo N, Seng BK, Li SC, 'Identification of factors influencing caregiving experience in caregivers of patients with schizophrenia', Annals of the Academy of Medicine Singapore, 32 43-45 (2003) [C1]
2003Li SC, 'An introduction to pharmacoeconomic evaluation in rheumatology', International Journal of Rheumatic Diseases, 6 192-200 (2003) [C1]
2003Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al., 'A comparison of the EQ-5D and the health utilities index mark 3 (HUI3) in patients with rheumatic diseases', Journal of Rheumatology, 30 2268-2274 (2003) [C1]
2003Koh Y, Fatimah MK, Li SC, 'Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study', Pharmacy World and Science: international journal of clinical pharmacy and pharmaceutical care, 25 135-137 (2003) [C1]
2003Luo N, Fong KH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Validity and Reliability of the EQ-5D Self-Report Questionnaire in Chinese-speaking Patients with Rheumatic Diseases in Singapore.', Ann Acad Med Singapore, 32 685-690 (2003) [C1]
2003Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J, et al., 'Do English and Chinese EQ-5D versions demonstrate measurement equivalence? An exploratory study', Health and Quality of Life Outcomes, 1 1-7 (2003) [C1]
2003Luo N, Li SC, Seng BK, Thumboo J, 'Construct Validity of the Health Utilities Index Mark 3 (HUI3) in Patients with Schizophrenia.', Qual Life Res, 7 (2003) [C1]
2003Chong LY, Chay OM, Li SC, 'Cultural adaptation and validation of Childhood Asthma Questionnaire-C (CAQ-C) in Singapore', Value in Health, 6(3) 374-375 (2003) [C3]
2003Wee HL, Li SC, 'Reliability and validity of KINDL children generic health-related quality of life questionnaire in an Asian school-based sample.', Value in Health, 6(3) (2003) [C3]
2003Luo N, Tan LCS, Li SC, Thumboo J, 'Validation of Singaporean English and Chinese EQ-5D Versions in Patients with Parkinsons Disease', Value in Health, 6 (6) 769-769 (2003) [C3]
2003Luo N, Fong KH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Validity and Reliability of the ED-5D Self-Report Questionnaire in English-speaking Asian Patients with Rheumatic Diseases in Singapore', Quality of Life Research, 12 87-92 (2003) [C3]
2003Luo N, Li SC, Seng BK, Thumboo J, 'Responsiveness of the Schizophrenia Quality of Life Scale (SQLS) and the Short Form 36 Health Survey (SF-36) in patients with Schizophrenia: A comparative Study.', Qual Life Res, 7 (2003) [C3]
2003Luo N, Seng BK, Li SC, Thumboo J, 'Health-related quality of life in outpatients with schizophrenia in Singapore', Value in Health, 6 (6) 695-695 (2003) [C3]
2002Tan LC, Luo N, Nazri M, Li SC, Thumboo J, 'Validity and Reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson''s Disease Patients in Singapore', Parkinsonism and Related Disorders, 10 493-499 (2002) [C1]
2002Luo N, Chew LH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Are Singaporean English and Chinese EQ-5D Versions psychometrically equivalent? An Exploratory Study', Quality of Life Research, 11 (2002) [C1]
2002Chong LY, Chay OM, Goh A, Seng YC, Li SC, 'Cultural adaptation and validation of Childhood Asthma Questionnaire Version B (CAQ-B) For Singapore Children.', Val Health, 5 (3) (2002) [C1]
2002Qeuk JT, Li SC, 'A Study of the effectiveness of AIDS health education interventions among the adolescent population of Singapore.', Singapore Medical Journal, 43 279-283 (2002) [C1]
2002Wee HL, Lee WW, Li SC, 'Psychometric evaluation of a generic HRQOL instrument (KID-KINDL) for self-assessment of HRQOL in Singaporean children with diabetes: A pilot study', Diab Res Clin Pract, 56(1) (2002) [C1]
2002Luo N, Chew LH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Comparing the EQ-5D and Health Utilities Index (HUI-3) in Subjects with Rheumatic Diseases.', Quality of Life Research, 11 (2002) [C1]
2002Wee WL, Ho HK, Li SC, 'Public awareness of diabetes mellitus in Singapore.', Singapore Medical Journal, 43 128-134 (2002) [C1]
2001Roy AN, Li SC, 'A Survey of Public Hospital Pharmacists in Singapore on their Views about The Formulary and its Decision-making Process.', Value in Health, 4 (2) (2001) [C1]
2001Luo N, Leng S, Fongs C, Li SC, 'Validation of the medical outcomes study short-form 36 health survey (SF-36) for quality-of-life assessment of Chinese patients with anxiety disorders in Singapore', Quality of Life Res, 9 (2001) [C1]
2001Wee HL, Lee WR, Li SC, 'Evaluation of a generic quality-of-life instrument (KINDL) for self-assessment of QOL in Singaporean children with diabetes: a pilot study.', Val Health, 0 510-510 (2001) [C3]
1996Wood PJ, IoannidesDemos LL, Li SC, Williams TJ, Hickey B, Spicer WJ, et al., 'Minimisation of aminoglycoside toxicity in patients with cystic fibrosis', THORAX, 51 369-373 (1996)
1994IOANNIDESDEMOS LL, LI SC, BASTONE EB, SPELMAN DW, HOOPER RE, COUSINS VC, MCLEAN AJ, 'ABSENCE OF TOXICITY IN PATIENTS WITH MALIGNANT OTITIS-EXTERNA FOLLOWING LONG-TERM TREATMENT WITH HIGH DOSAGE TOBRAMYCIN', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 34 267-274 (1994)
1994MCLEAN AJ, BASTONE EB, IOANNIDESDEMOS LL, LI SC, CHRISTOPHIDIS N, SPICER WJ, 'INTERACTION OF GENTAMICIN PEAK AND TROUGH CONCENTRATIONS ON BACTERIAL KILL', CLINICAL PHARMACOLOGY & THERAPEUTICS, 55 192-192 (1994)
1993BASTONE EB, LI SC, IOANNIDESDEMOS LI, SPICER WJ, MCLEAN AJ, 'KILL KINETICS AND REGROWTH PATTERNS OF ESCHERICHIA-COLI EXPOSED TO GENTAMICIN CONCENTRATION-TIME PROFILES SIMULATING INVIVO BOLUS AND INFUSION DOSING', ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 37 914-917 (1993)
1993IOANNIDESDEMOS LL, LI SC, BASTONE EB, SPICER WJ, 'BACTERICIDAL EFFECTS OF GENTAMICIN PEAK CONCENTRATIONS PROVIDE A RATIONALE FOR BOLUS ADMINISTRATION', CLINICAL PHARMACOLOGY & THERAPEUTICS, 53 194-194 (1993)
1993MCLEAN AJ, IOANNIDESDEMOS LL, LI SC, BASTONE EB, SPICER WJ, 'BACTERICIDAL EFFECT OF GENTAMICIN PEAK CONCENTRATION PROVIDES A RATIONALE FOR ADMINISTRATION OF BOLUS DOSES', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 32 301-305 (1993)
1993IOANNIDESDEMOS LL, LI SC, SPELMAN DW, HOOPER RE, COUSINS V, BASTONE EB, MCLEAN AJ, 'RATIONALE AND INITIAL EXPERIENCE OF HIGH-DOSE AMINOGLYCOSIDE THERAPY OF MALIGNANT OTITIS-EXTERNA', CLINICAL PHARMACOLOGY & THERAPEUTICS, 53 194-194 (1993)
1992CORVAIA L, LI SC, IOANNIDESDEMOS LL, BOWES G, SPICER WJ, SPELMAN DW, et al., 'A PROSPECTIVE-STUDY OF THE EFFECTS OF ORAL PROBENECID ON THE PHARMACOKINETICS OF INTRAVENOUS TICARILLIN IN PATIENTS WITH CYSTIC-FIBROSIS', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 30 875-878 (1992)
1992LI SC, IOANNIDESDEMOS LL, SPICER WJ, SPELMAN DW, TONG N, MCLEAN AJ, 'PROSPECTIVE AUDIT OF AN AMINOGLYCOSIDE CONSULTATIVE SERVICE IN A GENERAL-HOSPITAL', MEDICAL JOURNAL OF AUSTRALIA, 157 308-311 (1992)
1991LI SC, BOWES G, IOANNIDESDEMOS LL, SPICER WJ, HOOPER RE, SPELMAN DW, et al., 'DOSAGE ADJUSTMENT AND CLINICAL OUTCOMES OF LONG-TERM USE OF HIGH-DOSE TOBRAMYCIN IN ADULT CYSTIC-FIBROSIS PATIENTS', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 28 561-568 (1991)
1989LI SC, IOANNIDESDEMOS LL, SPICER WJ, BERBATIS C, SPELMAN DW, TONG N, MCLEAN AJ, 'PROSPECTIVE AUDIT OF AMINOGLYCOSIDE USAGE IN A GENERAL-HOSPITAL WITH ASSESSMENTS OF CLINICAL PROCESSES AND ADVERSE CLINICAL OUTCOMES', MEDICAL JOURNAL OF AUSTRALIA, 151 224-& (1989)
Show 142 more

Review (3 outputs)

YearCitationAltmetricsLink
2005Zhang J, Tian Q, Chan SY, Duan W, Li SC, Zhu YZ, Zhou SF, 'Metabolism and Transport of Oxazaphosphorines and the Clinical Implications.', Drug Metabolism Review (2005) [D1]
2004Zhou S, Chan E, Li SC, Huang M, Li X, Zhang Q, 'Predicting pharmacokinetic herb-drug in', Drug Metabolism and Drug Interaction (2004) [D1]
2003Li SC, 'An Overview of Community pharmacist interventions: Assessing cost-effectiveness and patients willingness to pay', Disease Management and Health Outcomes (2003) [D1]

Conference (92 outputs)

YearCitationAltmetricsLink
2013Gao L, Walterfang M, Velakoulis D, Li SC, 'VALIDATION OF A CHINESE VERSION OF NEUROPSYCHIATRY UNIT COGNITIVE ASSESSMENT TOOL (NUCOG)', VALUE IN HEALTH (2013)
2012Thoopputra T, Li SC, Newby DA, Schneider JJ, 'Pharmaceutical care intervention for disease management in community pharmacies in Australia', Value in Health: ISPOR 15th Annual European Congress and ISPOR 5th Asia-Pacific Conference, Berlin, Germany (2012) [E3]

Co-authors: David Newby

2012Tu HAT, Coyte P, Li SC, Postma MJ, 'Cost-effectiveness of rotavirus immunization in Vietnam: Exploring impacts of herd immunity and patterns of breastfeeding of', Value in Health: ISPOR 15th Annual European Congress and ISPOR 5th Asia-Pacific Conference, Berlin, Germany (2012) [E3]
2012Zhang F, Li SC, Du J, 'SATISFACTION ASSESSMENT OF INSURANCE SYSTEM FOR URBAN RESIDENTS (URMS) OF UNIVERSITY STUDENTS IN SHENYANG', VALUE IN HEALTH (2012) [E3]
2012Gao L, Li SC, 'Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in patients with type 2 diabetes in China', Value in Health, Berlin, Germany (2012) [E3]
2012Zhao F, Xie F, Li SC, 'Transferability of indirect cost of chronic disease: A systematic review and meta-analysis', Value in Health: ISPOR 15th Annual European Congress and ISPOR 5th Asia-Pacific Conference, Berlin, Germany (2012) [E3]
2012Zhang F, Du J, Li SC, 'Satisfaction assessment of insurance system for urban residents (URMS) of university students in Shenyang', Value in Health, Washington, DC (2012) [E3]
2012Gao L, Li SC, 'Statin is a reasonable treatment option for patients with polysystic ovary syndrome: A meta-analysis of randomized controlled trials', Value in Health, Berlin, Germany (2012) [E3]
2012Thoopputra T, Newby DA, Schneider JJ, Li SC, 'Awareness and perception of diabetes risk assessment in community pharmacy in Australia', Research in Social and Administrative Pharmacy: Workshop and Presentation Abstracts from the 17th International Social Pharmacy Workshop, Phuket, Thailand (2012) [E3]

Co-authors: David Newby

2011Tu HAT, Rozenbaum M, Coyte PC, Li SC, Postma MJ, 'Cost-effectiveness of rotavirus immunization in Vietnam: Results and challenges', Value in Health, Baltimore, MD (2011) [E3]
2011Zhang F, Li SC, Fu S, Xie J, Zhang Y, Kong L, 'What is important during the pharmacoeconomic evaluation of CAM (complementary and alternative medicine)?- A survey research', Value in Health, Baltimore, MD (2011) [E3]
2011Thoopputra T, Li SC, Newby DA, Schneider JJ, 'A literature review of diabetes risk assessment tools', Value in Health, Baltimore, MD (2011) [E3]

Co-authors: David Newby

2010Pongmesa T, Wee HL, Li SC, 'Health status, health-related quality of life and treatment satisfaction among patients with diabetes in Thailand', Value in Health, Phuket, Thailand (2010) [E3]
2010Xie F, Pullenayegum E, Li SC, 'Use of disease-specific instrument in economic evaluations: Mapping Womac into the EQ-5D utility index', Value in Health, Atlanta, GA (2010) [E3]
2010Zhao F, Yue M, Yang H, Wang T, Wu JH, Li SC, 'Health-related quality of life in Chinese chronic prostatitis patients', Value in Health, Phuket, Thailand (2010) [E3]
2010Tu HAT, Riewpaiboon A, Woerdenbag HJ, Postma MJ, Li SC, 'Cost-of-illness of chronic hepatitis B infection in Vietnam', Value in Health, Phuket, Thailand (2010) [E3]
2010Zhao F, Yue M, Yang H, Wang T, Wu JH, Li SC, 'Willingness to pay per quality adjusted life-year: Is one threshold applicable for all decision-making', Value in Health, Phuket, Thailand (2010) [E3]
2010Zhao FL, Yue M, Wu JH, Yang H, Wang T, Li SC, 'VALIDATION AND COMPARISON OF EUROQOL AND SHORT FORM 6D IN CHINESE CHRONIC PROSTATITIS PATIENTS', VALUE IN HEALTH (2010) [E3]
2010Xie F, Pullenayegum E, Li SC, 'USE OF A DISEASE-SPECIFIC INSTRUMENT IN ECONOMIC EVALUATIONS: MAPPING WOMAC ONTO THE EQ-5D UTILITY INDEX', VALUE IN HEALTH (2010) [E3]
2010Zhao F, Yue M, Wu JH, Yang H, Wang T, Li SC, 'Validation and comparison of euroqol and short form 6D in chronic prostatitis patients', Value in Health, Atlanta, GA (2010) [E3]
2010Pongmesa T, Li SC, Wee HL, 'Development of a Thai version of The Audit of Diabetes-Dependent Quality of Life (ADDQOL-19) Questionnaire: Linguistic and psychometric evaluation', Value in Health, Phuket, Thailand (2010) [E3]
2009Zhao YJ, Tan LC, Seah SH, Lau PN, Au WL, Li SC, et al., 'Rate of disease progression among patients with Parkinson's disease in Singapore', Value in Health, Orlando, FL (2009) [E3]
2009Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC, 'EXTENSION FROM INPATIENTS TO OUTPATIENTS: PERFORMANCE OF THE OXFORD KNEE SCORE IN MEASURING HEALTH OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS', VALUE IN HEALTH (2009) [E3]
2009Zhao F, Li SC, 'A systematic review of burden of disease studies in the Asia-Pacific region', Value in Health, Orlando, FL (2009) [E3]
2009Zhao FL, Li SC, 'A SYSTEMATIC REVIEW OF BURDEN OF DISEASE STUDIES IN THE ASIA-PACIFIC REGION', VALUE IN HEALTH (2009) [E3]
2009Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC, 'Extension from inpatients to outpatients: Performance of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis', Value in Health, Orlando, FL (2009) [E3]
2009Zhao YJ, Tan LC, Seah SH, Lau PN, Au WL, Li SC, et al., 'RATE OF DISEASE PROGRESSION AMONG PATIENTS WITH PARKINSON'S DISEASE IN SINGAPORE', VALUE IN HEALTH (2009) [E3]
2009Zhao F, Wu JH, Yue M, Li SC, 'Willingness to pay per quality-adjusted life year of chronic prostatits patients in China', Value in Health, Paris, France (2009) [E3]
2008Pongmesa T, Li SC, Wee HL, 'A comparison of diabetes knowledge among residents in Bangkok and other central provinces of Thailand', Value in Health, Athens, Greece (2008) [E3]
2008Li SC, Nguyen T, 'Cost analysis between valproate and lithium in the management of biopolar disorder: Results from a multinational study (Vlaid study - valproate versus lithium in bipolar disorders', ISPOR 3rd Asia-Pacific Conference. Abstracts, Seoul, South Korea (2008) [E3]
2008Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N, 'Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson's disease questionnaire (PDQ-8)', Value in Health, Toronto, ONT (2008) [E3]
2008Pongmesa T, Wee HL, Li SC, 'A survey of diabetes knowledge among the general population in Thailand', ISPOR 3rd Asia-Pacific Conference. Abstracts, Seoul, South Korea (2008) [E3]
2007Jin J, Sklar GE, Oh MS, Li SC, 'What factors affect compliance of hypertensive patients with their treatment?: A qualitative study', Value in Health, Dublin, Ireland (2007) [E3]
2007Zhang XH, Li SC, Xie F, Lo NN, Yang KY, Yeo SJ, Thomboo J, 'Investigation of response shift in health-related quality of life among patients undergoing total knee replacement', Value in Health, Dublin, Ireland (2007) [E3]
2007Ong SC, Lim SG, Li SC, 'Cultural Adaptation and Validation of A Health-Related Quality of Life Questionnaire for English-speaking Hepatitis B patients in Singapore', Arlington, West Virginia, USA (2007) [E4]
2007Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N, 'Identifications of Factors Affecting Quality of Life in Patients with Parkinsons Disease', Budapest, Hungary (2007) [E4]
2007Ngorsuraches S, Lerkiatbundit S, Li SC, Sirithorn R, Korwiwattanakarn M, 'Development and Validation of Patients Trust Scale in Community Pharmacist (TRUST-Ph)', Atlanta, USA, (2007) [E4]
2006Zhang XH, Ngorsuraches S, Li SC, 'Development and Validation of a scale to measure patients trust in pharmacists', Proceedings of 18th Singapore Pharmacy Congress, Singapore (2006) [E1]
2006Zhang XH, Ngorsuraches S, Li SC, 'Development and Validation of a scale to measure patients trust in pharmacists', Proceedings of the ISPOR 11th Annual International Meeting, Philadelphia, PA, USA, (2006) [E1]
2006Zhang XH, Xie F, Wee HL, Thumboo J, Li SC, 'Applying the Expectancy-Value Model to understand Health Preference - An Exploratory Study.', -, Philadelphia, PA, USA, (2006) [E1]
2006Wee HL, Li SC, Xie F, Zhang XH, Luo N, Cheung YB, et al., 'Feasibility and acceptability of TTO and SG and factors influencing their acceptance for health valuation among Singaporeans', Proceedings of ISPOR 2nd Asia Pacific Conference, Shanghai (2006) [E3]
2006Wee HL, Li SC, Xie F, Zhang XH, Luo N, Cheung YB, et al., 'The impact of talking about death on health state valuation: A study among Chinese and Indian Singaporeans', Proceedings of ISPOR 2nd Asia Pacific Conference, Shanghai (2006) [E3]
2006Koh Y, Lee YM, Fatimah MK, Li SC, 'The Economic Value of Pharmacists - Participation in Physicians-Pharmacists Review Team.', Proceedings of 18th Singapore Pharmacy Congress, Singapore (2006) [E3]
2006Wee HL, Li SC, Xie F, Zhang XH, Luo N, Cheung YB, et al., 'How do survey respondents interpret and utilize symbols used in health valuation studies', Proceedings of ISPOR 2nd Asia Pacific Conference, Shanghai (2006) [E3]
2006Koh Y, Yap C, Li SC, 'Developing a qualitative scoring system for adverse drug reaction assessment using genetic algorithm', ISPOR 2nd Asia-Pacific Conference, Shanghai (2006) [E3]
2006Ngorsuraches S, Li SC, 'Barriers to pharmaceutical care in Thailand', ISPOR 2nd Asia-Pacific Conference, Shanghai (2006) [E3]
2006Li SC, Zhang X, Xie F, Luo N, Cheung Y, Machin D, et al., ''The Impact of Discussing Death on Health Preferences: A Pilot Study in A Multi-Ethnic Asian Population', 17th Annual EuroQol Group Plenary Meeting, Barcelona (2006) [E3]
2006Jin J, Li SC, 'A Review of Factors affecting Therapeutic Compliance', Proceedings of 18th Singapore Pharmacy Congress, Singapore (2006) [E3]
2006Li SC, Iloeje U, Yuan Y, Lim S, ''A modelled economic implication of replacing lamivudine with entecavir in chronic hepatitis B (ChB) patients in Singapore.', Proceedings of 21st Annual Scientific Meeting of Singapore Society of Gastroenterologists, Singapore (2006) [E3]
2006Koh Y, Lee Y, Fatimah M, Ang Y, Li SC, ''The Clinical & Economic Value of Pharmacists Participation in Physicians-Pharmacists Review Team', Proceedings of National Healthcare Group Annual Scientific Congress, Singapore (2006) [E3]
2006Fong K, Lo N, Yeo S, Yang K, Li SC, Xie F, Thumboo J, 'Are they measurable? A Study on Eliciting Indirect and Intangible Costs of Knee Osteoarthritis Using Human Capital Approach and Willingness-to-Pay in Multiethnic Asian Population in Singapore.', Value in Health, Copenhagen (2006) [E3]
2006Yap K, Su J, Li SC, Ho P, ''Nanoparticulate Delivery System of Carboplatin', Proceedings of 18th Singapore Pharmacy Congress, Singapore (2006) [E3]
2005Lau TC, Lim BP, Li SC, 'Cost-Effectiveness Analysis of Bisphosphonates and Raloxifene for Treatment of Osteoporosis and Prevention of Fractures.', -, Washington, DC, USA (2005) [E1]
2005Zhang XH, Wee HL, Tan K, Tan HH, Thumboo J, Li SC, 'An Exploratory Study of the Equivalence between the English and Chinese Versions of the Audit of Diabetes-Dependent Quality of Life (ADDQOL) based on the Universalist Approach.', Quality of Life Research, San Francisco, USA (2005) [E1]
2005Xie F, Thumboo J, Li SC, 'Are they Relevant? A Critical Evaluation of the International Classification of Functioning, Disability and Health Core Sets for Osteoarthritis from the Perspective of Patients with Knee Osteoarthritis in Singapore', -, Palazzo Degli Affari, Florence, Italy (2005) [E1]
2005Lim X, Wong L, Li SC, 'Usage of Alternative and Complementary Medicines in Singapore', Proceedings of 17th Singapore Pharmacy Congress, Singapore (2005) [E3]
2005Wee Y, Chui W, Li SC, 'A Study of Pharmacists - Understanding, Attitude. And Practice of Pharmaceutical Care in Singapore', Proceedings of 17th Singapore Pharmacy Congress & Inaugural NUS Pharmacy Intervarsity Congress, Singapore (2005) [E3]
2005Zhang XH, Zhang XH, Wee HL, Wee HL, Tan K, Tan K, et al., 'Is Diabetes Knowledge Associated with Health-related Quality of Life among English-speaking Subjects with Diabetes in Singapore?', Washington, DC, USA (2005) [E3]
2005Guo X, Tan S, Luo N, Li SC, 'The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation of English and Chinese Versions in Singapore', Proceedings of 15th Science Research Congress, Singapore (2005) [E3]
2005Wee HL, Zhang XH, Tan K, Tan HH, Thumboo J, Li SC, 'Reliability and Validity of the General Diabetes Knowledge Test', Washington, DC, USA (2005) [E4]
2005Ong SC, Lim SG, Yeoh KY, Li SC, 'A Cost Analysis of Chronic Hepatitis B Infection & Its Associated Complications in Singapore', Singapore (2005) [E4]
2004Tan CE, Thumboo J, Wee HL, Goh SY, Li SC, Lim SG, Ong SC, 'Is the influence of sociodemographic factors on EQ-5D scores affected by the underlying disease: A study in patients with cronic hepatitis B or diabetes mellitus.', Quality of Life Research 2005, Hong-Kong (2004) [E1]
2004Koh Y, Fatimah HK, Fatimah MK, Li SC, 'Prevalence of drug-related problems amongst hospitalised patients on polypharmacy in Singapore.', Arlington, West Virginia, USA (2004) [E1]
2004Xie F, Luo N, Li SC, 'The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30): Validation of English version in Singapore', Arlington, West Virginia, USA (2004) [E1]
2004Wee HL, Goh SY, Li SC, Tan CE, Thumboo J, 'Does the generic EQ-5D function as well as disease-specific ADDQOL in persons with diabetes?', Hong Kong (2004) [E4]
2004Li SC, 'Pharmacoeconomics: Uses in Practice and Research in Singapore', Beijing, China (2004) [E4]
2003Chong LY, Chay OM, Li SC, 'Cultural adaptation and validation of Childhood Asthma Questionnaire-C', Value in health 2003, Virginia USA (2003) [E1]
2003Wee HL, Li SC, 'Reliability and validity of KINDL children generic health related quality of life questionnaire in an Asian school based sample', Value in Health, Virginia USA (2003) [E1]
2003Luo N, Seng BK, Thumboo J, Li SC, 'Health-related quality of life in outptients with schizophrenia in Singapore.', Value in Health, Barcelona Spain (2003) [E1]
2003Luo N, Li SC, Seng BK, Thumboo J, 'Construct Validity of the Health Utilities Index Mark 3 (HUI3) in Patients with Schizophrenia.', Quality of Life Research 2003, Prague Czech Republic (2003) [E1]
2003Luo N, Li SC, Seng BK, Thumboo J, 'Responsiveness of the Schizophrenia Quality of Life Scale (SQLS) and the Short Form 36 Health Survey (SF-36) in patients with Schizophrenia: a comparative study.', Quality of Life Research 2003, Prague Czech Republic (2003) [E1]
2003Luo N, Tan LC, Li SC, Thumboo J, 'Validation of Singaporean English and Chinese EQ-5D Versions in Patients with Parkinsons Disease', Value in health 6, Barcelona Spain (2003) [E1]
2003Ang Y, Chiu W, Li SC, 'Survey of Community Pharmacists on the Provision of Professional Advice to consumers who seeks self-medication for minor aliment management', Proceedings of 16th Singapore Pharmacy Congress, Singapore (2003) [E3]
2003Luo N, Seng BK, Thumboo J, Li SC, 'Validation of English and Chinese versions of the SQLS, the SF-36 and the HUI3 in Patients with Schizophrenia in Singapore.', Value in Health, USA (2003) [E3]
2003Seng B, Luo N, Li SC, ''The psychological distress in caregivers of patients with schizophrenia in Singapore', Proceedings of the NHG Annual Scientific Congress 2003, Singapore (2003) [E3]
2003Koh Y, Chan C, Li SC, ''Comparison of five established adverse drug reaction algorithms in a patient sample in Singapore', Proceedings of European Society of Clinical Pharmacy 4th Spring Conference, Lisbon (2003) [E3]
2003Keung X, Chiu W, Li SC, ''A survey of consumers on the provision of professional advice given by community pharmacists on self-medication', 16th Singapore Pharmacy Congress, Singapore (2003) [E3]
2002Chong LY, Chay OM, Goh A, Seng YC, Li SC, 'Cultural adaptation and validation of Childhood Asthma Questionnaire Version B (CAQ-B) For Singapore Children.', Arlington, Virginia, USA (2002) [E1]
2002Luo N, Chew LH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Are Singaporean English and Chinese EQ-5D Versions psychometrically equivalent? An Exploratory Study', Orlando, USA (2002) [E1]
2002Vascoo S, Li SC, Thumboo J, Luo N, Chew LH, Koh DR, et al., 'Comparing the EQ-5D and Health Utilities Index (HUI-3) in Subjects with Rheumatic Diseases.', Orlando, USA (2002) [E1]
2002Wee HL, Lee WW, Li SC, 'Psychometric evaluation of a generic HRQOL instrument (KID-KINDL) for self-assessment of HRQOL in Singaporean children with diabetes: A pilot study', Beijing, China (2002) [E1]
2002Li SC, 'A Survey on Consumers - Behaviours in the Purchase of Medicines', First Health Sciences Authority Scientific Seminar, Singapore (2002) [E3]
2002Fatimah M, Li SC, ''Pilot Study to quantify the Extent of Polypharmacy in Alexandra Hospital in the Geriatric Population', Proceedings of 15th Singapore Pharmacy Congress, Singapore (2002) [E3]
2002Li SC, Yeoh T, Yeo S, Lin R, ''An Audit of Antimicrobial Surgical Prophylaxis in Pediatric Patients in Singapore', Proceedings of FIP 62nd International Congress, Nice (2002) [E3]
2002Luo N, Seng B, Thumboo J, Li SC, 'Validation of the Schizophrenia Quality of Life Scale (SQLS) and the Short Form 36 Health Survey (SF-36) in English-speaking Patients with Schizophrenia in Singapore', Proceedings of the 1st Scientific Meeting of the National Healthcare Group, Singapore (2002) [E3]
2002Koh Y, Fatimah M, Li SC, 'Prevalence of Drug Therapy Related Hospital Admission and its Association with Polypharmacy and Age of Patients in Singapore', Proceedings of 15th Singapore Pharmacy Congress, Singapore (2002) [E3]
2002Seng B, Luo N, Li SC, ''Validation of the Experience of Caregiving Inventory (ECI) and the Burden Assessment Scale (BAS) in English-speaking Caregivers of Patients with Schizophrenia in Singapore', Proceedings of the 1st Scientific Meeting of the National Healthcare Group, Singapore (2002) [E3]
2001Roy AN, Li SC, 'A Survey of Public Hospital Pharmacists in Singapore on their Views about The Formulary and its Decision-making Process.', Arlington, VA, USA (2001) [E1]
2001Luo N, Chew LH, Fong KY, Ng SC, Yoon KH, Li SC, Thumboo J, 'Validity and Reliability of EQ-50 Domains in Asians in Singapore with Rheumatic Diseases', Amsterdam, The Netherlands (2001) [E1]
2001Luo N, Leng S, Fongs C, Li SC, 'Validation of the medical outcomes study short-form 36 health survey (SF-36) for quality-of-life assessment of Chinese patients with anxiety disorders in Singapore' (2001) [E1]
2001Ku H, Tan M, Li SC, 'Attitude and knowledge towards Traditional Medicine among Singaporeans', Singapore Traditional Chinese Medicine (TCM) Research Symposium 2001, Singapore (2001) [E3]
2001Luo N, Fones C, Li SC, 'A study of the Quality of Life in patients with anxiety disorders in Singapore', Proceedings of FIP 61st International Congress, Singapore (2001) [E3]
Show 89 more
Edit

Grants and Funding

Summary

Number of grants1
Total funding$15,000

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2012 (1 grants)

TBA$15,000
Funding Body: Newcastle & Hunter Valley Pharmacists Association Inc

Project Team
Professor Shu Chuen Li, Mr Hao Hu
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$15,00020122014
GNo:G1200632
Edit

Research Supervision

Number of current supervisions11
Total current UoN PhD EFTSL4.6

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20142018PhD (Pharmacy)Principal SupervisorIdentification and Classification of Adverse Drug Reactions in China: Development and Validation of a Quantitative Combined System Using Generic Algorith
20132017PhD (Pharmacy)Principal SupervisorAdverse Drug Reactions in Paediatrics Patient
20122020PhD (Clinical Pharm)Co-SupervisorPotential Cardio-Protective Effect of Pneumococcal Vaccine
20122016PhD (Pharmacy)Principal SupervisorHealth Related Quality of Life and Economic Burden of Prevalent Chronic Diseases in China
20112015PhD (Pharmacy)Principal SupervisorRelationship Between Health Related Quality of Life (HRQoL), Status of Cognitive Impairment Among Patients with Epilepsy, and the Economic Burden of Epilepsy in China
20082016PhD (Pharmacy)Principal SupervisorPharmacovigilance and development of signal detection algorithm for drug safety monitoring
20082012PhD(Experimental Pharmacology)Principal SupervisorThe Cost Effective Management of Osteoporosis to Prevent Fractures in Singapore
20062008Masters Pharmacy
National University of Singapore
Principal SupervisorImpact of therapeutic compliance on clinical and economic outcomes
20062009PHD Pharmacy
National University of Singapore
Principal SupervisorA comparison of the impact of pharmaceutical care in diabetic patients in Singapore and Thailand
20062009PHD Pharmacy
National University of Singapore
Principal SupervisorPharmacoeconomic study of Parkinson's Disease in Singapore
20052008PHD Pharmacy
National University of Singapore
Principal SupervisorMethodlogical Issues in Pharmacoeconomics and Outcomes Research

Past Supervision

YearProgramSupervisor TypeResearch Title
2014PhD (Pharmacy)Principal SupervisorRisk Management for Type 2 Diabetes in Community Pharmacy Practice
2011PhD(Experimental Pharmacology)Principal SupervisorEvidence-Based Reimbursement Decision-Making in Asia-Pacific Region: Transferability of the Economic Evaluation Between Different Jurisdictions
Edit

Professor Shu Chuen Li

Work Phone(02) 4921 5921
Fax(02) 492 17903
Email
PositionProfessor
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine
The University of Newcastle, Australia
Focus AreaPharmacy and Experimental Pharmacology
Office
MS108,
Medical Sciences,
Callaghan
University Drive
Callaghan NSW 2308
Australia
URL:www.newcastle.edu.au/profile/shuchuen-li